NO20034026L - Nytt preparat - Google Patents

Nytt preparat

Info

Publication number: NO20034026L
Authority: NO; Norway
Prior art keywords: new preparation; preparation; new
Prior art date: 2001-03-15

Application number

NO20034026A

Other languages

English (en)

Other versions

NO20034026D0 (no

Inventor

Britta Siekmann

Barbro Thoring

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-03-15

Filing date

2003-09-11

Publication date

2003-11-11

2003-09-11 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-09-11 Publication of NO20034026D0 publication Critical patent/NO20034026D0/no

2003-11-11 Publication of NO20034026L publication Critical patent/NO20034026L/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Biophysics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20034026A 2001-03-15 2003-09-11 Nytt preparat NO20034026L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0100901A SE0100901D0 (sv)	2001-03-15	2001-03-15	New composition
PCT/SE2002/000476 WO2002074282A1 (en)	2001-03-15	2002-03-13	New composition

Publications (2)

Publication Number	Publication Date
NO20034026D0 NO20034026D0 (no)	2003-09-11
NO20034026L true NO20034026L (no)	2003-11-11

Family

ID=20283373

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20034026A NO20034026L (no)	2001-03-15	2003-09-11	Nytt preparat

Country Status (13)

Country	Link
US (1)	US20040096494A1 (no)
EP (1)	EP1370239A1 (no)
JP (1)	JP2004523577A (no)
KR (1)	KR20030082971A (no)
CN (1)	CN1496253A (no)
BR (1)	BR0207760A (no)
CA (1)	CA2435825A1 (no)
IL (1)	IL156818A0 (no)
MX (1)	MXPA03007093A (no)
NO (1)	NO20034026L (no)
SE (1)	SE0100901D0 (no)
WO (1)	WO2002074282A1 (no)
ZA (1)	ZA200306282B (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9700866B2 (en)	2000-12-22	2017-07-11	Baxter International Inc.	Surfactant systems for delivery of organic compounds
US8067032B2 (en)	2000-12-22	2011-11-29	Baxter International Inc.	Method for preparing submicron particles of antineoplastic agents
US20060003012A9 (en)	2001-09-26	2006-01-05	Sean Brynjelsen	Preparation of submicron solid particle suspensions by sonication of multiphase systems
JP2005504090A (ja)	2001-09-26	2005-02-10	バクスター・インターナショナル・インコーポレイテッド	分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
GB0207529D0 (en) *	2002-04-02	2002-05-08	Norbrook Lab Ltd	Injectable veterinary composition for small animals
US20040018237A1 (en) *	2002-05-31	2004-01-29	Perricone Nicholas V.	Topical drug delivery using phosphatidylcholine
US7163958B2 (en)	2002-07-03	2007-01-16	Nitromed Inc.	Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
US20060127468A1 (en)	2004-05-19	2006-06-15	Kolodney Michael S	Methods and related compositions for reduction of fat and skin tightening
DK1758590T3 (da) *	2004-05-19	2011-11-21	Los Angeles Biomed Res Inst	Anvendelse af et detergent til ikke-kirurgisk fjernelse af fedt
US7754230B2 (en) *	2004-05-19	2010-07-13	The Regents Of The University Of California	Methods and related compositions for reduction of fat
EP1886667A1 (en) *	2006-08-08	2008-02-13	The Jordanian Pharmaceutical Manufacturing Co. Ltd.	Microemulsified drug formulation
US8101593B2 (en)	2009-03-03	2012-01-24	Kythera Biopharmaceuticals, Inc.	Formulations of deoxycholic acid and salts thereof
US20120237492A1 (en)	2011-02-18	2012-09-20	Kythera Biopharmaceuticals, Inc.	Treatment of submental fat
CN103547258B (zh) *	2011-03-17	2017-10-20	特兰斯德梅尔生物工艺股份有限公司	局部一氧化氮***及其使用方法
US8653058B2 (en)	2011-04-05	2014-02-18	Kythera Biopharmaceuticals, Inc.	Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US8871254B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871262B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Compositions and methods for treatment of osteoporosis and other indications
US8871257B2 (en) *	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871260B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Methods and compositions for muscular and neuromuscular diseases
US8871261B2 (en) *	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Cancer treatments and compositions for use thereof
US8871255B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Treatment of skin and soft tissue infection with nitric oxide
US8871256B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871258B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Treatment and prevention of learning and memory disorders
US8871259B2 (en)	2012-09-19	2014-10-28	Transdermal Biotechnology, Inc.	Techniques and systems for treatment of neuropathic pain and other indications
US9295647B2 (en)	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Systems and methods for delivery of peptides
US9314417B2 (en) *	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Treatment of skin, including aging skin, to improve appearance
US9320758B2 (en)	2013-03-13	2016-04-26	Transdermal Biotechnology, Inc.	Brain and neural treatments comprising peptides and other compositions
US9320706B2 (en)	2013-03-13	2016-04-26	Transdermal Biotechnology, Inc.	Immune modulation using peptides and other compositions
US9339457B2 (en)	2013-03-13	2016-05-17	Transdermal Biotechnology, Inc.	Cardiovascular disease treatment and prevention
US9393264B2 (en) *	2013-03-13	2016-07-19	Transdermal Biotechnology, Inc.	Immune modulation using peptides and other compositions
US9387159B2 (en) *	2013-03-13	2016-07-12	Transdermal Biotechnology, Inc.	Treatment of skin, including aging skin, to improve appearance
US9393265B2 (en)	2013-03-13	2016-07-19	Transdermal Biotechnology, Inc.	Wound healing using topical systems and methods
US20140271938A1 (en) *	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Systems and methods for delivery of peptides
US9295636B2 (en)	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Wound healing using topical systems and methods
US20140271937A1 (en) *	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Brain and neural treatments comprising peptides and other compositions
US20140271731A1 (en) *	2013-03-13	2014-09-18	Transdermal Biotechnology, Inc.	Cardiovascular disease treatment and prevention
US9314423B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Hair treatment systems and methods using peptides and other compositions
US9295637B2 (en) *	2013-03-13	2016-03-29	Transdermal Biotechnology, Inc.	Compositions and methods for affecting mood states
US9724419B2 (en)	2013-03-13	2017-08-08	Transdermal Biotechnology, Inc.	Peptide systems and methods for metabolic conditions
US9687520B2 (en)	2013-03-13	2017-06-27	Transdermal Biotechnology, Inc.	Memory or learning improvement using peptide and other compositions
US9241899B2 (en) *	2013-03-13	2016-01-26	Transdermal Biotechnology, Inc.	Topical systems and methods for treating sexual dysfunction
US9314433B2 (en)	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Methods and systems for treating or preventing cancer
US9849160B2 (en) *	2013-03-13	2017-12-26	Transdermal Biotechnology, Inc.	Methods and systems for treating or preventing cancer
US9314422B2 (en) *	2013-03-13	2016-04-19	Transdermal Biotechnology, Inc.	Peptide systems and methods for metabolic conditions
US9750787B2 (en)	2013-03-13	2017-09-05	Transdermal Biotechnology, Inc.	Memory or learning improvement using peptide and other compositions
ES2882287T3 (es) *	2017-02-21	2021-12-01	Dsm Ip Assets Bv	Uso de una composición de pienso para reducir la emisión de metano en rumiantes y/o mejorar el rendimiento de los rumiantes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4622219A (en) *	1983-06-17	1986-11-11	Haynes Duncan H	Method of inducing local anesthesia using microdroplets of a general anesthetic
GB8630273D0 (en) *	1986-12-18	1987-01-28	Til Medical Ltd	Pharmaceutical delivery systems
CA1319886C (en) *	1987-02-03	1993-07-06	Alberto Ferro	Mixed micelle solutions
SE9704833D0 (sv) *	1997-12-22	1997-12-22	Astra Ab	New formulation

2001
- 2001-03-15 SE SE0100901A patent/SE0100901D0/xx unknown
2002
- 2002-03-13 KR KR10-2003-7011860A patent/KR20030082971A/ko not_active Application Discontinuation
- 2002-03-13 BR BR0207760-4A patent/BR0207760A/pt not_active Application Discontinuation
- 2002-03-13 EP EP02704035A patent/EP1370239A1/en not_active Withdrawn
- 2002-03-13 IL IL15681802A patent/IL156818A0/xx unknown
- 2002-03-13 CA CA002435825A patent/CA2435825A1/en not_active Abandoned
- 2002-03-13 US US10/471,378 patent/US20040096494A1/en not_active Abandoned
- 2002-03-13 WO PCT/SE2002/000476 patent/WO2002074282A1/en not_active Application Discontinuation
- 2002-03-13 CN CNA028065271A patent/CN1496253A/zh active Pending
- 2002-03-13 JP JP2002572990A patent/JP2004523577A/ja active Pending
- 2002-03-13 MX MXPA03007093A patent/MXPA03007093A/es not_active Application Discontinuation
2003
- 2003-08-13 ZA ZA200306282A patent/ZA200306282B/en unknown
- 2003-09-11 NO NO20034026A patent/NO20034026L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
KR20030082971A (ko)	2003-10-23
SE0100901D0 (sv)	2001-03-15
CN1496253A (zh)	2004-05-12
CA2435825A1 (en)	2002-09-26
WO2002074282A1 (en)	2002-09-26
EP1370239A1 (en)	2003-12-17
IL156818A0 (en)	2004-02-08
JP2004523577A (ja)	2004-08-05
ZA200306282B (en)	2004-11-23
US20040096494A1 (en)	2004-05-20
MXPA03007093A (es)	2003-11-18
BR0207760A (pt)	2004-06-01
NO20034026D0 (no)	2003-09-11

Legal Events

Date	Code	Title	Description
2005-11-14	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20034026L (no)	2003-11-11	Nytt preparat
NO20035208D0 (no)	2003-11-24	Nytt vaksine preparat
NO20033143L (no)	2003-09-19	Farmasoytisk preparat
IS7016A (is)	2003-11-05	Ný 4-anilínókínólín-3-karboxamíð
NO20030418L (no)	2003-01-27	Nytt farmasöytisk preparat
DK1671949T3 (da)	2008-11-03	Substituerede pyridinylaminer
NO20052239D0 (no)	2005-05-06	Fast preparat
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
NO20034695L (no)	2003-12-03	Nytt preparat
NO20025805D0 (no)	2002-12-03	Farmasöytisk preparat
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
NO20060375L (no)	2006-01-24	Famasoytisk preparat
NO20033829D0 (no)	2003-08-28	Antiviralt preparat
ATE435197T1 (de)	2009-07-15	Substituierte 4-aminocyclohexanole
NO20023392D0 (no)	2002-07-12	Preparat
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
ATA13992002A (de)	2003-10-15	Schlackengranulierungsanlage
DE60216967D1 (de)	2007-02-01	Substituierte cyclohexanderivate
AT500276B1 (de)	2006-06-15	Radschwenksystem
DE60215160D1 (de)	2006-11-16	Starterrückspulschutzhaube
SE0004779D0 (sv)	2000-12-22	Preparat
ATA6162001A (de)	2002-11-15	Schneekette
SE0100199D0 (sv)	2001-01-24	New formulation
NO20015559D0 (no)	2001-11-14	Kreklinggel±
SE0102054D0 (sv)	2001-06-08	New Combination